PSA doubling time of prostate carcinoma managed with watchful observation alone

This publication has 12 references indexed in Scilit:

• Observations of prostate specific antigen doubling time in Japanese patients with nonmetastatic prostate carcinoma
  Cancer, 1999
• EVALUATION OF CHANGES IN PROSTATE SPECIFIC ANTIGEN IN CLINICALLY LOCALIZED PROSTATE CANCER MANAGED WITHOUT INITIAL THERAPY
  Journal of Urology, 1998
• Pretreatment prostate-specific antigen doubling times: clinical utility of this predictor of prostate cancer behavior
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1996
• Observations of pretreatment prostate-specific antigen doubling time in 107 patients referred for definitive radiotherapy
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
• Natural History of Changes in Prostate Specific Antigen in Early Stage Prostate Cancer
  Journal of Urology, 1994
• Linear regressive analysis using prostate-specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancer
  Cancer, 1993
• Observations on the doubling time of prostate cancer.The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume
  Cancer, 1993
• Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. II. Radical Prostatectomy Treated Patients
  Journal of Urology, 1989
• Latent Prostatic Cancer in a Consecutive Autopsy Series
  Scandinavian Journal of Urology and Nephrology, 1980
• Etiology, epidemiology, and pathology of prostatic cancer
  Cancer, 1973